Cargando…

Comparison of Survival Times for Dogs with Pituitary‐Dependent Hyperadrenocorticism in a Primary‐Care Hospital: Treated with Trilostane versus Untreated

BACKGROUND: Although pituitary‐dependent hyperadrenocorticism (PDH) is one of the most common endocrinopathies in dogs, the effects of withholding treatment on survival time in dogs with PDH remain unclear. HYPOTHESIS/OBJECTIVES: The purpose of this study was to clarify the effects of treatment in d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagata, N., Kojima, K., Yuki, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259634/ https://www.ncbi.nlm.nih.gov/pubmed/27906457 http://dx.doi.org/10.1111/jvim.14617

Ejemplares similares

Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
por: Arenas Bermejo, Carolina, et al.
Publicado: (2020)

Cortisol Concentrations in Well‐Regulated Dogs with Hyperadrenocorticism Treated with Trilostane
por: Midence, J.N., et al.
Publicado: (2015)

Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment
por: García San José, Paula, et al.
Publicado: (2020)

Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism
por: Nam, Sookin, et al.
Publicado: (2021)

Comparison of methods to monitor dogs with hypercortisolism treated with trilostane
por: Golinelli, Stefania, et al.
Publicado: (2021)

Clinical Relationship between Cholestatic Disease and Pituitary‐Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series
por: Kim, K.‐h., et al.
Publicado: (2017)

The interpretive contribution of the baseline serum cortisol concentration of the ACTH stimulation test in the diagnosis of pituitary dependent hyperadrenocorticism in dogs
por: Nivy, Ran, et al.
Publicado: (2018)

Effect of Trilostane and Mitotane on Aldosterone Secretory Reserve in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Reid, L.E., et al.
Publicado: (2014)

Effect of Trilostane on Hormone and Serum Electrolyte Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Griebsch, C., et al.
Publicado: (2013)

Utility of a corticotropin‐releasing hormone test to differentiate pituitary‐dependent hyperadrenocorticism from cortisol‐producing adrenal tumors in dogs
por: Tanaka, Sachiyo, et al.
Publicado: (2021)

Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism
por: Aldridge, C., et al.
Publicado: (2016)

Effect of pituitary‐dependent hypercortisolism on the survival of dogs treated with radiotherapy for pituitary macroadenomas
por: Rapastella, Sofia, et al.
Publicado: (2023)

The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism
por: ODA, Hitomi, et al.
Publicado: (2016)

Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism
por: García San José, Paula, et al.
Publicado: (2020)

Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane
por: Bergmann, Michèle, et al.
Publicado: (2020)

Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog
por: Park, Su‐Min, et al.
Publicado: (2021)

Diabetes mellitus remission in a cat with pituitary-dependent hyperadrenocorticism after trilostane treatment
por: Muschner, Adriana Cunha, et al.
Publicado: (2018)

Evaluation of individual low‐dose dexamethasone suppression test patterns in naturally occurring hyperadrenocorticism in dogs
por: Bennaim, Michael, et al.
Publicado: (2018)

Erratum for “Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism”
Publicado: (2022)

Long‐Term Survival of Dogs with Adrenal‐Dependent Hyperadrenocorticism: A Comparison between Mitotane and Twice Daily Trilostane Treatment
por: Arenas, C., et al.
Publicado: (2014)

The Influence of Pituitary Size on Outcome After Transsphenoidal Hypophysectomy in a Large Cohort of Dogs with Pituitary‐Dependent Hypercortisolism
por: van Rijn, S.J., et al.
Publicado: (2016)

Serum Cortisol Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism and Atypical Hyperadrenocorticism
por: Frank, L.A., et al.
Publicado: (2014)

Serum Bile Acids Concentrations and Liver Enzyme Activities after Low-Dose Trilostane in Dogs with Hyperadrenocorticism
por: Tinted, Nannicha, et al.
Publicado: (2023)

Presumed pituitary apoplexy in 26 dogs: Clinical findings, treatments, and outcomes
por: Woelfel, Christian W., et al.
Publicado: (2023)

Clinical Utility of Diagnostic Laboratory Tests in Dogs with Acute Pancreatitis: A Retrospective Investigation in a Primary Care Hospital
por: Yuki, M., et al.
Publicado: (2016)

Effects of Toceranib Phosphate on the Hypothalamic‐Pituitary‐Thyroid Axis in Tumor‐Bearing Dogs
por: Hume, K.R., et al.
Publicado: (2017)

Concurrent pituitary and adrenocortical lesions on computed tomography imaging in dogs with spontaneous hypercortisolism
por: van Bokhorst, Kirsten L., et al.
Publicado: (2018)

Effects of Levothyroxine Administration and Withdrawal on the Hypothalamic‐Pituitary‐Thyroid Axis in Euthyroid Dogs
por: Ziglioli, V., et al.
Publicado: (2017)

Long‐term survival of dogs treated for gallbladder mucocele by cholecystectomy, medical management, or both
por: Parkanzky, Max, et al.
Publicado: (2019)

Clinical assessment of heartworm‐infected Beagles treated with a combination of imidacloprid/moxidectin and doxycycline, or untreated
por: Savadelis, Molly D., et al.
Publicado: (2020)

Response and survival of dogs with proteinuria (UPC > 2.0) treated with angiotensin converting enzyme inhibitors
por: Fulton, Emily A., et al.
Publicado: (2023)

Comparison of Adrenocorticotropic Hormone Stimulation Test Results Started 2 versus 4 Hours after Trilostane Administration in Dogs with Naturally Occurring Hyperadrenocorticism
por: Bonadio, C.M., et al.
Publicado: (2014)

Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs
por: Macfarlane, L., et al.
Publicado: (2016)

Factors associated with survival in dogs with chronic kidney disease
por: Rudinsky, Adam J., et al.
Publicado: (2018)

Clinical features, diagnosis, and survival analysis of dogs with glioma
por: José‐López, Roberto, et al.
Publicado: (2021)

Clinical findings and survival time in dogs with advanced heart failure
por: Beaumier, Amelie, et al.
Publicado: (2018)

Serum Adipokine Concentrations in Dogs with Naturally Occurring Pituitary‐Dependent Hyperadrenocorticism
por: Cho, K.‐D., et al.
Publicado: (2013)

Differentiation of stable kidney function versus progressive dysfunction in dogs
por: Cowgill, Larry D., et al.
Publicado: (2023)

Hyperlipasemia in dogs with acute kidney injury treated with and without hemodialysis
por: Bendeler, Kim S., et al.
Publicado: (2023)

Primary hemostatic function in dogs with acute kidney injury
por: McBride, Duana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uiaa8rqlkr95jh8bn6ltm9rd2p